Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 371

    1.

    Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes.

    Kellogg AP, Wiggin TD, Larkin DD, Hayes JM, Stevens MJ, Pop-Busui R.

    Diabetes. 2007 Dec;56(12):2997-3005. Epub 2007 Aug 24.PMID: 17720896 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes.

    Kellogg AP, Converso K, Wiggin T, Stevens M, Pop-Busui R.

    Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H453-61. Epub 2008 Dec 5.PMID: 19060127 [PubMed - indexed for MEDLINE]Related articles

    3.

    Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress.

    Kellogg AP, Pop-Busui R.

    Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1521-9.PMID: 16356116 [PubMed - indexed for MEDLINE]Related articles

    4.

    Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.

    Pop-Busui R, Marinescu V, Van Huysen C, Li F, Sullivan K, Greene DA, Larkin D, Stevens MJ.

    Diabetes. 2002 Aug;51(8):2619-28.PMID: 12145179 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.

    Vareniuk I, Pacher P, Pavlov IA, Drel VR, Obrosova IG.

    Int J Mol Med. 2009 May;23(5):571-80.PMID: 19360314 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Cyclooxygenase-2 pathway as a potential therapeutic target in diabetic peripheral neuropathy.

    Kellogg AP, Cheng HT, Pop-Busui R.

    Curr Drug Targets. 2008 Jan;9(1):68-76. Review.PMID: 18220714 [PubMed - indexed for MEDLINE]Related articles

    7.

    A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.

    Drel VR, Pacher P, Vareniuk I, Pavlov I, Ilnytska O, Lyzogubov VV, Tibrewala J, Groves JT, Obrosova IG.

    Eur J Pharmacol. 2007 Aug 13;569(1-2):48-58. Epub 2007 Jun 9.PMID: 17644085 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.

    Elias KA, Cronin MJ, Stewart TA, Carlsen RC.

    Diabetes. 1998 Oct;47(10):1637-42.PMID: 9753304 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of the diacylglycerol complexing agent, cremophor, on nerve-conduction velocity and perfusion in diabetic rats.

    Jack AM, Cameron NE, Cotter MA.

    J Diabetes Complications. 1999 Jan-Feb;13(1):2-9.PMID: 10232703 [PubMed - indexed for MEDLINE]Related articles

    10.

    Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.

    Ho EC, Lam KS, Chen YS, Yip JC, Arvindakshan M, Yamagishi S, Yagihashi S, Oates PJ, Ellery CA, Chung SS, Chung SK.

    Diabetes. 2006 Jul;55(7):1946-53.PMID: 16804062 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.

    Obrosova IG, Xu W, Lyzogubov VV, Ilnytska O, Mashtalir N, Vareniuk I, Pavlov IA, Zhang J, Slusher B, Drel VR.

    Free Radic Biol Med. 2008 Mar 15;44(6):972-81. Epub 2007 Oct 3.PMID: 17976390 [PubMed - indexed for MEDLINE]Related articles

    12.

    Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.

    Vareniuk I, Pavlov IA, Obrosova IG.

    Diabetologia. 2008 Nov;51(11):2126-33. Epub 2008 Sep 19.PMID: 18802679 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.

    Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA.

    Diabetes. 2000 Jun;49(6):1006-15.PMID: 10866054 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.

    Vareniuk I, Pavlov IA, Drel VR, Lyzogubov VV, Ilnytska O, Bell SR, Tibrewala J, Groves JT, Obrosova IG.

    Exp Neurol. 2007 Jun;205(2):425-36. Epub 2007 Mar 27.PMID: 17475250 [PubMed - indexed for MEDLINE]Related articles

    15.

    The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.

    Drel VR, Mashtalir N, Ilnytska O, Shin J, Li F, Lyzogubov VV, Obrosova IG.

    Diabetes. 2006 Dec;55(12):3335-43.PMID: 17130477 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.

    Cameron NE, Cotter MA, Maxfield EK.

    Diabetologia. 1993 Apr;36(4):299-304.PMID: 8477873 [PubMed - indexed for MEDLINE]Related articles

    17.

    Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.

    Li F, Szabó C, Pacher P, Southan GJ, Abatan OI, Charniauskaya T, Stevens MJ, Obrosova IG.

    Diabetologia. 2004 Apr;47(4):710-7.PMID: 15298348 [PubMed - indexed for MEDLINE]Related articles

    18.

    Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.

    Leonelli E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura LM, Lauria G, Magnaghi V, Roglio I, Melcangi RC.

    Neuroscience. 2007 Feb 23;144(4):1293-304. Epub 2006 Dec 20.PMID: 17187935 [PubMed - indexed for MEDLINE]Related articles

    19.

    The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy.

    Low PA, Nickander KK, Tritschler HJ.

    Diabetes. 1997 Sep;46 Suppl 2:S38-42.PMID: 9285497 [PubMed - indexed for MEDLINE]Related articles

    20.

    Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.

    Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA.

    Diabetes Care. 1995 Aug;18(8):1160-7.PMID: 7587852 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data